A 22-plex Chemiluminescent Microarray for Pneumococcal Antibodies
Open Access
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 128 (1) , 23-31
- https://doi.org/10.1309/781k5w6qh7jh2tma
Abstract
We developed a chemiluminescent multiplexed microarray that simultaneously determines IgG antibody concentrations to 22 pneumococcal polysaccharide (PnPs) serotypes (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 23F, and 33F). We compared the microarray with an enzyme-linked immunosorbent assay (ELISA) for 9 of the 22 serotypes (1, 4, 5, 6B, 9V, 14, 18C, 19F, and 23F). Correlation coefficients (r2) for the comparison of the microarray with ELISA ranged from 0.91 to 0.97 for the 9 serotypes. The microarray detected more than 4-fold increases in antibody concentrations in serum samples from before and 1 month after administration of pneumococcal vaccine for all 22 serotypes tested. The mean interassay and intra-assay coefficients of variation for 12 serum samples for the 22 serotypes were 7.6% and 6.0%, respectively. Inhibition-of-binding studies showed more than 90% inhibition by homologous serotypes and, with few exceptions, less than 25% inhibition by heterologous serotypes. The microarray multiplexing technology is an attractive alternative to ELISA for antibody responses to 23-valent PnPs vaccines.Keywords
This publication has 2 references indexed in Scilit:
- Immunodeficiency DisordersHematology-American Society Hematology Education Program, 2003
- Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and TreatmentClinical Infectious Diseases, 1992